BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24821728)

  • 41. The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties.
    Redner RL; Chen JD; Rush EA; Li H; Pollock SL
    Blood; 2000 Apr; 95(8):2683-90. PubMed ID: 10753851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides.
    Beez S; Demmer P; Puccetti E
    PLoS One; 2012; 7(11):e48636. PubMed ID: 23152790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity.
    Kang SI; Chang WJ; Cho SG; Kim IY
    J Biol Chem; 2003 Dec; 278(51):51479-83. PubMed ID: 14527952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
    Savickiene J; Treigyte G; Magnusson KE; Navakauskiene R
    Ann N Y Acad Sci; 2009 Aug; 1171():321-33. PubMed ID: 19723072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute promyelocytic leukemia and variant fusion proteins: PLZF-RARα fusion protein at a glance.
    Hussain L; Maimaitiyiming Y; Islam K; Naranmandura H
    Semin Oncol; 2019 Apr; 46(2):133-144. PubMed ID: 31126665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of PML and PML-RARalpha in Mad-mediated transcriptional repression.
    Khan MM; Nomura T; Kim H; Kaul SC; Wadhwa R; Shinagawa T; Ichikawa-Iwata E; Zhong S; Pandolfi PP; Ishii S
    Mol Cell; 2001 Jun; 7(6):1233-43. PubMed ID: 11430826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks.
    Morey L; Brenner C; Fazi F; Villa R; Gutierrez A; Buschbeck M; Nervi C; Minucci S; Fuks F; Di Croce L
    Mol Cell Biol; 2008 Oct; 28(19):5912-23. PubMed ID: 18644863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A.
    Jeon BN; Kim MK; Choi WI; Koh DI; Hong SY; Kim KS; Kim M; Yun CO; Yoon J; Choi KY; Lee KR; Nephew KP; Hur MW
    Cancer Res; 2012 Mar; 72(5):1137-48. PubMed ID: 22253232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia.
    Licht JD; Shaknovich R; English MA; Melnick A; Li JY; Reddy JC; Dong S; Chen SJ; Zelent A; Waxman S
    Oncogene; 1996 Jan; 12(2):323-36. PubMed ID: 8570209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Stat5-RARalpha fusion protein represses transcription and differentiation through interaction with a corepressor complex.
    Maurer AB; Wichmann C; Gross A; Kunkel H; Heinzel T; Ruthardt M; Groner B; Grez M
    Blood; 2002 Apr; 99(8):2647-52. PubMed ID: 11929749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
    Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
    Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Guidez F; Howell L; Isalan M; Cebrat M; Alani RM; Ivins S; Hormaeche I; McConnell MJ; Pierce S; Cole PA; Licht J; Zelent A
    Mol Cell Biol; 2005 Jul; 25(13):5552-66. PubMed ID: 15964811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Sternsdorf T; Puccetti E; Jensen K; Hoelzer D; Will H; Ottmann OG; Ruthardt M
    Mol Cell Biol; 1999 Jul; 19(7):5170-8. PubMed ID: 10373566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
    Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW
    Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia.
    Martens JH; Brinkman AB; Simmer F; Francoijs KJ; Nebbioso A; Ferrara F; Altucci L; Stunnenberg HG
    Cancer Cell; 2010 Feb; 17(2):173-85. PubMed ID: 20159609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.
    Ruthardt M; Testa U; Nervi C; Ferrucci PF; Grignani F; Puccetti E; Grignani F; Peschle C; Pelicci PG
    Mol Cell Biol; 1997 Aug; 17(8):4859-69. PubMed ID: 9234742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.
    Koken MH; Daniel MT; Gianni M; Zelent A; Licht J; Buzyn A; Minard P; Degos L; Varet B; de Thé H
    Oncogene; 1999 Jan; 18(4):1113-8. PubMed ID: 10023688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Sp1-like protein BTEB3 inhibits transcription via the basic transcription element box by interacting with mSin3A and HDAC-1 co-repressors and competing with Sp1.
    Kaczynski J; Zhang JS; Ellenrieder V; Conley A; Duenes T; Kester H; van Der Burg B; Urrutia R
    J Biol Chem; 2001 Sep; 276(39):36749-56. PubMed ID: 11477107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.